- Written by ClinicalTrials.gov
- Category: Joint Diseases
Interventions: Drug: Tofacitinib (Xeljanz); Drug: Etanercept, other Biologics, Disease-modifying antirheumatic drugs (DMARDs), etc
Sponsors: Pfizer; Pfizer
Enrolling by invitation - verified August 2013
- Details